Perspective: cancer vaccines in the era of immune checkpoint blockade

by Cebon, Jonathan
Published in Mamm Genome (2018)

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti‐PD‐1 Therapy

by Parakh, Sagun, Cebon, Jonathan, Klein, Oliver
Published in Oncologist (2018)

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

by Gunjur, Ashray, Klein, Oliver, Kee, Damien, Cebon, Jonathan
Published in J Immunother Cancer (2019)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells

by Woods, Katherine, Pasam, Anupama, Jayachandran, Aparna, Andrews, Miles C., Cebon, Jonathan
Published in Front Oncol (2014)

Embryonic Chicken Transplantation is a Promising Model for Studying the Invasive Behavior of Melanoma Cells

by Jayachandran, Aparna, McKeown, Sonja J., Woods, Briannyn L., Prithviraj, Prashanth, Cebon, Jonathan
Published in Front Oncol (2015)

A pilot study of intrahepatic yttrium‐90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver‐only metastases

by Arulananda, Surein, Parakh, Sagun, Palmer, Jodie, Goodwin, Mark, Andrews, Miles C., Cebon, Jonathan
Published in Cancer Rep (Hoboken) (2019)

The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations

by Vella, Laura J, Andrews, Miles C, Pasam, Anupama, Woods, Katherine, Behren, Andreas, Cebon, Jonathan S
Published in Oncoimmunology (2014)

Characterising the phenotypic evolution of circulating tumour cells during treatment

by Tsao, Simon Chang-Hao, Wang, Jing, Wang, Yuling, Behren, Andreas, Cebon, Jonathan, Trau, Matt
Published in Nat Commun (2018)

Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle–Associated PDGFRβ()

by Vella, Laura J., Behren, Andreas, Coleman, Bradley, Greening, David W., Hill, Andrew F., Cebon, Jonathan
Published in Neoplasia (2017)

A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

by Ebert, Lisa M., MacRaild, Sarah E., Zanker, Damien, Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Published 2012

Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma

by Parker, Robert, Vella, Laura J., Xavier, Dylan, Amirkhani, Ardeshir, Parker, Jimmy, Cebon, Jonathan, Molloy, Mark P.
Published in Front Oncol (2015)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations

by Chang-Hao Tsao, Simon, Weiss, Jonathan, Hudson, Christopher, Christophi, Christopher, Cebon, Jonathan, Behren, Andreas, Dobrovic, Alexander
Published in Sci Rep (2015)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma

by Woods, Katherine, Knights, Ashley J., Anaka, Matthew, Schittenhelm, Ralf B., Purcell, Anthony W., Behren, Andreas, Cebon, Jonathan
Published in J Immunother Cancer (2016)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma

by Andrews, Miles C., Cursons, Joseph, Hurley, Daniel G., Anaka, Matthew, Cebon, Jonathan S., Behren, Andreas, Crampin, Edmund J.
Published in Mol Cancer (2016)

PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation

by Tutuka, Candani S. A., Andrews, Miles C., Mariadason, John M., Ioannidis, Paul, Hudson, Christopher, Cebon, Jonathan, Behren, Andreas
Published in Mol Cancer (2017)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion

by Prithviraj, Prashanth, Anaka, Matthew, McKeown, Sonja J, Permezel, Michael, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas, Jayachandran, Aparna
Published in Oncotarget (2015)

Alternate antigen processing in the presence of gamma interferon may misdirect the immune recognition of cancer

by Woods, Katherine, Schittenhelm, Ralf B, Heesterbeek, Dani, Knights, Ashley, Anaka, Matthew, Purcell, Anthony W, Behren, Andreas, Cebon, Jonathan
Published in J Immunother Cancer (2015)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

by Prithviraj, Prashanth, McArthur, Grant, Atkinson, Victoria, Parente, Phillip, Andrews, Miles, Parakh, Sagun, Millward, Michael, Cebon, Jonathan, Klein, Oliver
Published in J Immunother Cancer (2015)

Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report

by Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Published in BMC Nephrol (2020)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors

by Anaka, Matthew, Hudson, Christopher, Lo, Pu-Han, Do, Hongdo, Caballero, Otavia L, Davis, Ian D, Dobrovic, Alexander, Cebon, Jonathan, Behren, Andreas
Published 2013